{"gene":"FEM1A","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2021,"finding":"FEM1A acts as a substrate receptor subunit of CRL2 (Cullin2-RING) E3 ubiquitin ligase complexes and recognizes arginine C-terminal degrons (Arg/C-degrons) on substrate proteins. Crystal structures of FEM1A in complex with Arg/C-degron-bearing substrates revealed that FEM1A and FEM1C selectively target distinct classes of Arg/C-degrons compared to FEM1B, a selectivity confirmed by binding assays and global protein stability (GPS) analyses.","method":"X-ray crystallography (structure of FEM1A/C bound to Arg/C-degron substrates), in vitro binding assays, global protein stability (GPS) analysis, mutagenesis","journal":"Nature chemical biology","confidence":"High","confidence_rationale":"Tier 1 — crystal structures with functional validation via binding assays and GPS, multiple orthogonal methods in a single rigorous study","pmids":["33398168"],"is_preprint":false},{"year":2017,"finding":"FEM1A (together with FEM1B and FEM1C) directly interacts with and mediates proteasomal degradation of Stem-Loop Binding Protein (SLBP), a conserved regulator of histone mRNA metabolism. FEM1A interacts with a distinct degron in the N-terminus of SLBP. An SLBP mutant unable to interact with FEM1A/B/C and cyclin F is expressed at higher levels and does not oscillate during the cell cycle, demonstrating that FEM1A contributes to cell-cycle-regulated SLBP turnover. The pathway is evolutionarily conserved: FEM1 orthologs interact with SLBP orthologs in C. elegans and Drosophila.","method":"Co-immunoprecipitation, interaction/binding assays with degron mutants, cell-cycle expression analysis, C. elegans RNAi knockdown with SLBP ortholog (CDL-1) upregulation readout, cross-species validation","journal":"Cell cycle (Georgetown, Tex.)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, degron mutant rescue, orthogonal genetic epistasis in C. elegans and Drosophila, replicated across organisms","pmids":["28118078"],"is_preprint":false},{"year":1998,"finding":"Mouse Fem1a encodes a protein containing seven sequential ankyrin (ANK) repeat domains, homologous to C. elegans FEM-1, a signal-transducing regulator in the sex-determination pathway. Fem1a is highly expressed in adult heart and skeletal muscle and is expressed during embryogenesis, suggesting a conserved role in vertebrate cell-fate determination.","method":"Gene cloning, sequence analysis, chromosomal mapping, Northern blot expression analysis","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 3 — cloning and expression characterization, domain architecture identified but no direct biochemical activity assay","pmids":["9828124"],"is_preprint":false},{"year":2009,"finding":"Mouse Fem1a protein is localized within mitochondria of C2C12 myoblasts and cardiac muscle cells. Fem1a expression is upregulated in mouse hearts after myocardial infarction (ischemia-reperfusion injury). Fem1a was also identified as a cellular binding partner of the EP4 receptor for prostaglandin E2.","method":"Immunofluorescence, electron microscopy, biochemical fractionation assays, specific antibody, ischemia-reperfusion mouse model","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — direct subcellular localization by multiple complementary methods (immunofluorescence, EM, fractionation); binding partner identified but mechanism not fully characterized","pmids":["19406122"],"is_preprint":false},{"year":2001,"finding":"Human FEM1A encodes a 617 amino acid protein with six N-terminal ankyrin repeat elements, localizes to chromosome 5q23.1, and is highly expressed in kidney and cardiac tissue. The ankyrin repeat domain is conserved from C. elegans fem-1, suggesting conservation of signaling function.","method":"cDNA cloning, genomic structure determination, chromosomal mapping (FISH/synteny), Northern blot expression analysis","journal":"Gene","confidence":"Low","confidence_rationale":"Tier 3 — characterization by cloning and expression; no direct biochemical or functional assay","pmids":["11733146"],"is_preprint":false},{"year":2005,"finding":"FEM1A expression is activated during myocyte differentiation of C2C12 myoblasts, is confined to terminally differentiating cells (not quiescent reserve/satellite-like cells), and is downregulated in all 8 tested human rhabdomyosarcoma (RMS) cell lines and in primary RMS from multiple mouse genetic models (Ptch1+/-, p53-/-, p53+/-;Ptch1+/-, HGF/SF-Ink4a/Arf-/-), implicating FEM1A in myogenic cell-fate determination.","method":"RT-PCR/Northern blot expression analysis during C2C12 differentiation, analysis of human RMS cell lines, mouse genetic RMS models","journal":"Tumour biology","confidence":"Low","confidence_rationale":"Tier 3 — loss-of-expression correlative data with no direct functional rescue or molecular mechanism established","pmids":["16254458"],"is_preprint":false}],"current_model":"FEM1A is a substrate receptor subunit of CUL2-RING E3 ubiquitin ligase (CRL2FEM1A) that recognizes arginine C-terminal degrons (Arg/C-degrons) via its ankyrin repeat domain to direct ubiquitin-mediated proteasomal degradation of substrates including SLBP; it localizes to mitochondria in muscle cells and interacts with the EP4 prostaglandin receptor, and its expression is regulated during myocyte differentiation and the cell cycle."},"narrative":{"teleology":[{"year":1998,"claim":"Cloning of mouse Fem1a established that vertebrates possess a homolog of C. elegans sex-determination factor FEM-1 containing seven ankyrin repeat domains, with preferential expression in heart and skeletal muscle, raising the question of whether it functions in cell-fate determination outside nematode sex determination.","evidence":"Gene cloning, sequence analysis, and Northern blot in mouse tissues","pmids":["9828124"],"confidence":"Medium","gaps":["No biochemical activity or binding partners identified","Functional role in muscle beyond expression pattern unknown","Relationship to ubiquitin-proteasome system not yet recognized"]},{"year":2001,"claim":"Characterization of the human FEM1A ortholog confirmed conservation of ankyrin repeat architecture and tissue expression (kidney, heart), establishing the gene's identity and genomic position but leaving its molecular function unknown.","evidence":"cDNA cloning, FISH chromosomal mapping, Northern blot in human tissues","pmids":["11733146"],"confidence":"Low","gaps":["No direct biochemical or functional assay performed","No interacting partners identified","Mechanism of action entirely uncharacterized"]},{"year":2005,"claim":"FEM1A expression was found to be activated specifically during terminal myocyte differentiation and consistently downregulated in rhabdomyosarcoma, linking it to myogenic cell-fate determination and suggesting a tumor-suppressive context.","evidence":"RT-PCR/Northern blot during C2C12 differentiation, expression analysis in human RMS lines and multiple mouse genetic RMS models","pmids":["16254458"],"confidence":"Low","gaps":["Correlative expression data only — no functional rescue or knockdown phenotype","Molecular targets and pathway placement undefined","Causality between FEM1A loss and tumorigenesis not tested"]},{"year":2009,"claim":"Subcellular localization of FEM1A to mitochondria in muscle cells and identification of the EP4 prostaglandin receptor as a binding partner provided the first spatial and interactome context, and upregulation after myocardial infarction suggested a stress-responsive role.","evidence":"Immunofluorescence, electron microscopy, biochemical fractionation in C2C12 myoblasts and cardiac cells; ischemia-reperfusion mouse model","pmids":["19406122"],"confidence":"Medium","gaps":["Functional consequence of EP4 interaction unknown","Whether mitochondrial localization is linked to ubiquitin ligase function unclear","Mechanism of upregulation after ischemia not addressed"]},{"year":2017,"claim":"Identification of SLBP as a direct degradation substrate of FEM1A (and FEM1B/C) via a distinct N-terminal degron established FEM1A as a ubiquitin-proteasome pathway component controlling cell-cycle-dependent histone mRNA metabolism, with evolutionary conservation from C. elegans to mammals.","evidence":"Co-immunoprecipitation, degron mutant analysis, cell-cycle expression profiling, C. elegans RNAi epistasis with CDL-1 readout","pmids":["28118078"],"confidence":"High","gaps":["Full substrate repertoire beyond SLBP not defined","Whether FEM1A recognizes SLBP via an Arg/C-degron or a different motif class not resolved","Relative contributions of FEM1A vs. FEM1B/C to SLBP turnover not quantified"]},{"year":2021,"claim":"Crystal structures of FEM1A bound to Arg/C-degron substrates revealed the structural basis of substrate recognition and demonstrated that FEM1A and FEM1C select distinct Arg/C-degron classes compared to FEM1B, establishing the molecular logic of degron selectivity within the FEM1 family.","evidence":"X-ray crystallography of FEM1A–degron complexes, in vitro binding assays, GPS analysis, mutagenesis","pmids":["33398168"],"confidence":"High","gaps":["Physiological substrates recognized via Arg/C-degrons in vivo not comprehensively catalogued","How degron selectivity among FEM1A/B/C is regulated in different tissues remains unclear","No structural information on FEM1A in complex with CUL2–RBX1 scaffold"]},{"year":null,"claim":"It remains unknown how FEM1A's mitochondrial localization in muscle cells relates to its CRL2 substrate receptor function, what the full in vivo substrate repertoire is, and whether FEM1A loss causally contributes to muscle disease or rhabdomyosarcoma.","evidence":"","pmids":[],"confidence":"Low","gaps":["No in vivo knockout phenotype reported","Mitochondrial vs. cytosolic CRL2 activity not reconciled","No disease-causative mutations identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1]}],"complexes":["CRL2^FEM1A (CUL2-RBX1-ELOB/C-FEM1A)"],"partners":["CUL2","SLBP","FEM1B","FEM1C","PTGER4"],"other_free_text":[]},"mechanistic_narrative":"FEM1A is a substrate receptor subunit of CUL2-RING E3 ubiquitin ligase complexes (CRL2^FEM1A) that recognizes arginine C-terminal degrons (Arg/C-degrons) on substrate proteins through its ankyrin repeat domain, directing their ubiquitin-mediated proteasomal degradation [PMID:33398168]. FEM1A, together with FEM1B and FEM1C, mediates the proteasomal degradation of Stem-Loop Binding Protein (SLBP) by recognizing a distinct N-terminal degron, contributing to cell-cycle-regulated SLBP turnover in an evolutionarily conserved pathway [PMID:28118078]. In muscle cells, FEM1A localizes to mitochondria, interacts with the EP4 prostaglandin receptor, and is upregulated following myocardial ischemia-reperfusion injury and during myocyte terminal differentiation [PMID:19406122, PMID:16254458]."},"prefetch_data":{"uniprot":{"accession":"Q9BSK4","full_name":"Protein fem-1 homolog A","aliases":["FEM1-alpha","Prostaglandin E receptor 4-associated protein"],"length_aa":669,"mass_kda":73.6,"function":"Substrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation (PubMed:29779948, PubMed:33398168, PubMed:33398170). The C-degron recognized by the DesCEND pathway is usually a motif of less than ten residues and can be present in full-length proteins, truncated proteins or proteolytically cleaved forms (PubMed:29779948, PubMed:33398168, PubMed:33398170). The CRL2(FEM1A) complex specifically recognizes proteins with an arginine at the C-terminus: recognizes and binds proteins ending with -Lys/Arg-Xaa-Arg and -Lys/Arg-Xaa-Xaa-Arg C-degrons, such as SIL1 or OR51B2, leading to their ubiquitination and degradation (PubMed:33398168, PubMed:33398170). Promotes ubiquitination and degradation of SLBP (PubMed:28118078). Involved in PGE2-EP4-mediated inhibition of inflammation of macrophages via interaction with NFKB1 and PTGER4 (By similarity). Promotes inflammation in brain microglia through MAP2K4/MKK4-mediated signaling (By similarity)","subcellular_location":"Mitochondrion; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9BSK4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/FEM1A","classification":"Not Classified","n_dependent_lines":74,"n_total_lines":1208,"dependency_fraction":0.061258278145695365},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/FEM1A","total_profiled":1310},"omim":[{"mim_id":"613539","title":"FEM1 HOMOLOG B; FEM1B","url":"https://www.omim.org/entry/613539"},{"mim_id":"613538","title":"FEM1 HOMOLOG A; FEM1A","url":"https://www.omim.org/entry/613538"},{"mim_id":"608767","title":"FEM1 HOMOLOG C; FEM1C","url":"https://www.omim.org/entry/608767"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"skeletal muscle","ntpm":256.2},{"tissue":"tongue","ntpm":113.3}],"url":"https://www.proteinatlas.org/search/FEM1A"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q9BSK4","domains":[{"cath_id":"1.25.40.20","chopping":"4-225","consensus_level":"medium","plddt":96.3697,"start":4,"end":225},{"cath_id":"-","chopping":"292-404","consensus_level":"medium","plddt":95.3956,"start":292,"end":404},{"cath_id":"-","chopping":"426-573","consensus_level":"medium","plddt":91.0147,"start":426,"end":573}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BSK4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BSK4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BSK4-F1-predicted_aligned_error_v6.png","plddt_mean":88.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FEM1A","jax_strain_url":"https://www.jax.org/strain/search?query=FEM1A"},"sequence":{"accession":"Q9BSK4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BSK4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BSK4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BSK4"}},"corpus_meta":[{"pmid":"33398168","id":"PMC_33398168","title":"Molecular basis for arginine C-terminal degron recognition by Cul2FEM1 E3 ligase.","date":"2021","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/33398168","citation_count":49,"is_preprint":false},{"pmid":"9828124","id":"PMC_9828124","title":"The murine fem1 gene family: homologs of the Caenorhabditis elegans sex-determination protein FEM-1.","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9828124","citation_count":43,"is_preprint":false},{"pmid":"28118078","id":"PMC_28118078","title":"FEM1 proteins are ancient regulators of SLBP degradation.","date":"2017","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/28118078","citation_count":31,"is_preprint":false},{"pmid":"25636508","id":"PMC_25636508","title":"Interaction of sonic hedgehog (SHH) pathway with cancer stem cell genes in gastric cancer.","date":"2015","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25636508","citation_count":30,"is_preprint":false},{"pmid":"14527725","id":"PMC_14527725","title":"The Fem1c genes: conserved members of the Fem1 gene family in vertebrates.","date":"2003","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/14527725","citation_count":23,"is_preprint":false},{"pmid":"10623617","id":"PMC_10623617","title":"Sequence, organization, and expression of the human FEM1B gene.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10623617","citation_count":22,"is_preprint":false},{"pmid":"18757445","id":"PMC_18757445","title":"FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome.","date":"2008","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18757445","citation_count":21,"is_preprint":false},{"pmid":"14960149","id":"PMC_14960149","title":"Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/14960149","citation_count":20,"is_preprint":false},{"pmid":"38663500","id":"PMC_38663500","title":"Evaluating the potential of daily intake of polystyrene microplastics via drinking water in inducing PCOS and its ovarian fibrosis progression using female zebrafish.","date":"2024","source":"NanoImpact","url":"https://pubmed.ncbi.nlm.nih.gov/38663500","citation_count":20,"is_preprint":false},{"pmid":"11733146","id":"PMC_11733146","title":"Identification of human FEM1A, the ortholog of a C. elegans sex-differentiation gene.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11733146","citation_count":19,"is_preprint":false},{"pmid":"25848829","id":"PMC_25848829","title":"De novo transcriptome sequencing to identify the sex-determination genes in Hyriopsis schlegelii.","date":"2015","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25848829","citation_count":16,"is_preprint":false},{"pmid":"33892462","id":"PMC_33892462","title":"Structural insights into SMCR8 C-degron recognition by FEM1B.","date":"2021","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/33892462","citation_count":14,"is_preprint":false},{"pmid":"34171686","id":"PMC_34171686","title":"Transcriptional changes revealed water acidification leads to the immune response and ovary maturation delay in the Chinese mitten crab Eriocheir sinensis.","date":"2021","source":"Comparative biochemistry and physiology. Part D, Genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/34171686","citation_count":12,"is_preprint":false},{"pmid":"16390781","id":"PMC_16390781","title":"FEM1A is a candidate gene for polycystic ovary syndrome.","date":"2005","source":"Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/16390781","citation_count":11,"is_preprint":false},{"pmid":"16254458","id":"PMC_16254458","title":"The Fem1a gene is downregulated in Rhabdomyosarcoma.","date":"2005","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16254458","citation_count":9,"is_preprint":false},{"pmid":"35384611","id":"PMC_35384611","title":"Comprehensive Transcriptome Analysis of Gonadal and Somatic Tissues for Identification of Sex-Related Genes in the Largemouth Bass Micropterus salmoides.","date":"2022","source":"Marine biotechnology (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35384611","citation_count":9,"is_preprint":false},{"pmid":"19406122","id":"PMC_19406122","title":"Fem1a is a mitochondrial protein up-regulated upon ischemia-reperfusion injury.","date":"2009","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19406122","citation_count":8,"is_preprint":false},{"pmid":"29321553","id":"PMC_29321553","title":"Prediction of co-expression genes and integrative analysis of gene microarray and proteomics profile of Keshan disease.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29321553","citation_count":8,"is_preprint":false},{"pmid":"34861280","id":"PMC_34861280","title":"Genomic structure, expression, and functional characterization of the Fem-1 gene family in the redclaw crayfish, Cherax quadricarinatus.","date":"2021","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34861280","citation_count":5,"is_preprint":false},{"pmid":"22678803","id":"PMC_22678803","title":"[Polymorphisms of FEM1A gene in patients with polycystic ovary syndrome].","date":"2012","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22678803","citation_count":1,"is_preprint":false},{"pmid":"40565326","id":"PMC_40565326","title":"Full-Length Transcriptome of Testis and Ovary Provides Insights into Alternative Splicing During Gonadal Development in Litopenaeus vannamei.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40565326","citation_count":0,"is_preprint":false},{"pmid":"21393897","id":"PMC_21393897","title":"Embryonal rhabdomyosarcoma of the adult soft palate.","date":"2011","source":"Indian journal of pathology & microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/21393897","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10790,"output_tokens":1683,"usd":0.028807},"stage2":{"model":"claude-opus-4-6","input_tokens":4918,"output_tokens":1825,"usd":0.105322},"total_usd":0.134129,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2021,\n      \"finding\": \"FEM1A acts as a substrate receptor subunit of CRL2 (Cullin2-RING) E3 ubiquitin ligase complexes and recognizes arginine C-terminal degrons (Arg/C-degrons) on substrate proteins. Crystal structures of FEM1A in complex with Arg/C-degron-bearing substrates revealed that FEM1A and FEM1C selectively target distinct classes of Arg/C-degrons compared to FEM1B, a selectivity confirmed by binding assays and global protein stability (GPS) analyses.\",\n      \"method\": \"X-ray crystallography (structure of FEM1A/C bound to Arg/C-degron substrates), in vitro binding assays, global protein stability (GPS) analysis, mutagenesis\",\n      \"journal\": \"Nature chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures with functional validation via binding assays and GPS, multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"33398168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"FEM1A (together with FEM1B and FEM1C) directly interacts with and mediates proteasomal degradation of Stem-Loop Binding Protein (SLBP), a conserved regulator of histone mRNA metabolism. FEM1A interacts with a distinct degron in the N-terminus of SLBP. An SLBP mutant unable to interact with FEM1A/B/C and cyclin F is expressed at higher levels and does not oscillate during the cell cycle, demonstrating that FEM1A contributes to cell-cycle-regulated SLBP turnover. The pathway is evolutionarily conserved: FEM1 orthologs interact with SLBP orthologs in C. elegans and Drosophila.\",\n      \"method\": \"Co-immunoprecipitation, interaction/binding assays with degron mutants, cell-cycle expression analysis, C. elegans RNAi knockdown with SLBP ortholog (CDL-1) upregulation readout, cross-species validation\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, degron mutant rescue, orthogonal genetic epistasis in C. elegans and Drosophila, replicated across organisms\",\n      \"pmids\": [\"28118078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Mouse Fem1a encodes a protein containing seven sequential ankyrin (ANK) repeat domains, homologous to C. elegans FEM-1, a signal-transducing regulator in the sex-determination pathway. Fem1a is highly expressed in adult heart and skeletal muscle and is expressed during embryogenesis, suggesting a conserved role in vertebrate cell-fate determination.\",\n      \"method\": \"Gene cloning, sequence analysis, chromosomal mapping, Northern blot expression analysis\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — cloning and expression characterization, domain architecture identified but no direct biochemical activity assay\",\n      \"pmids\": [\"9828124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Mouse Fem1a protein is localized within mitochondria of C2C12 myoblasts and cardiac muscle cells. Fem1a expression is upregulated in mouse hearts after myocardial infarction (ischemia-reperfusion injury). Fem1a was also identified as a cellular binding partner of the EP4 receptor for prostaglandin E2.\",\n      \"method\": \"Immunofluorescence, electron microscopy, biochemical fractionation assays, specific antibody, ischemia-reperfusion mouse model\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct subcellular localization by multiple complementary methods (immunofluorescence, EM, fractionation); binding partner identified but mechanism not fully characterized\",\n      \"pmids\": [\"19406122\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Human FEM1A encodes a 617 amino acid protein with six N-terminal ankyrin repeat elements, localizes to chromosome 5q23.1, and is highly expressed in kidney and cardiac tissue. The ankyrin repeat domain is conserved from C. elegans fem-1, suggesting conservation of signaling function.\",\n      \"method\": \"cDNA cloning, genomic structure determination, chromosomal mapping (FISH/synteny), Northern blot expression analysis\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — characterization by cloning and expression; no direct biochemical or functional assay\",\n      \"pmids\": [\"11733146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"FEM1A expression is activated during myocyte differentiation of C2C12 myoblasts, is confined to terminally differentiating cells (not quiescent reserve/satellite-like cells), and is downregulated in all 8 tested human rhabdomyosarcoma (RMS) cell lines and in primary RMS from multiple mouse genetic models (Ptch1+/-, p53-/-, p53+/-;Ptch1+/-, HGF/SF-Ink4a/Arf-/-), implicating FEM1A in myogenic cell-fate determination.\",\n      \"method\": \"RT-PCR/Northern blot expression analysis during C2C12 differentiation, analysis of human RMS cell lines, mouse genetic RMS models\",\n      \"journal\": \"Tumour biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — loss-of-expression correlative data with no direct functional rescue or molecular mechanism established\",\n      \"pmids\": [\"16254458\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FEM1A is a substrate receptor subunit of CUL2-RING E3 ubiquitin ligase (CRL2FEM1A) that recognizes arginine C-terminal degrons (Arg/C-degrons) via its ankyrin repeat domain to direct ubiquitin-mediated proteasomal degradation of substrates including SLBP; it localizes to mitochondria in muscle cells and interacts with the EP4 prostaglandin receptor, and its expression is regulated during myocyte differentiation and the cell cycle.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FEM1A is a substrate receptor subunit of CUL2-RING E3 ubiquitin ligase complexes (CRL2^FEM1A) that recognizes arginine C-terminal degrons (Arg/C-degrons) on substrate proteins through its ankyrin repeat domain, directing their ubiquitin-mediated proteasomal degradation [PMID:33398168]. FEM1A, together with FEM1B and FEM1C, mediates the proteasomal degradation of Stem-Loop Binding Protein (SLBP) by recognizing a distinct N-terminal degron, contributing to cell-cycle-regulated SLBP turnover in an evolutionarily conserved pathway [PMID:28118078]. In muscle cells, FEM1A localizes to mitochondria, interacts with the EP4 prostaglandin receptor, and is upregulated following myocardial ischemia-reperfusion injury and during myocyte terminal differentiation [PMID:19406122, PMID:16254458].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Cloning of mouse Fem1a established that vertebrates possess a homolog of C. elegans sex-determination factor FEM-1 containing seven ankyrin repeat domains, with preferential expression in heart and skeletal muscle, raising the question of whether it functions in cell-fate determination outside nematode sex determination.\",\n      \"evidence\": \"Gene cloning, sequence analysis, and Northern blot in mouse tissues\",\n      \"pmids\": [\"9828124\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical activity or binding partners identified\", \"Functional role in muscle beyond expression pattern unknown\", \"Relationship to ubiquitin-proteasome system not yet recognized\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Characterization of the human FEM1A ortholog confirmed conservation of ankyrin repeat architecture and tissue expression (kidney, heart), establishing the gene's identity and genomic position but leaving its molecular function unknown.\",\n      \"evidence\": \"cDNA cloning, FISH chromosomal mapping, Northern blot in human tissues\",\n      \"pmids\": [\"11733146\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct biochemical or functional assay performed\", \"No interacting partners identified\", \"Mechanism of action entirely uncharacterized\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"FEM1A expression was found to be activated specifically during terminal myocyte differentiation and consistently downregulated in rhabdomyosarcoma, linking it to myogenic cell-fate determination and suggesting a tumor-suppressive context.\",\n      \"evidence\": \"RT-PCR/Northern blot during C2C12 differentiation, expression analysis in human RMS lines and multiple mouse genetic RMS models\",\n      \"pmids\": [\"16254458\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Correlative expression data only — no functional rescue or knockdown phenotype\", \"Molecular targets and pathway placement undefined\", \"Causality between FEM1A loss and tumorigenesis not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Subcellular localization of FEM1A to mitochondria in muscle cells and identification of the EP4 prostaglandin receptor as a binding partner provided the first spatial and interactome context, and upregulation after myocardial infarction suggested a stress-responsive role.\",\n      \"evidence\": \"Immunofluorescence, electron microscopy, biochemical fractionation in C2C12 myoblasts and cardiac cells; ischemia-reperfusion mouse model\",\n      \"pmids\": [\"19406122\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of EP4 interaction unknown\", \"Whether mitochondrial localization is linked to ubiquitin ligase function unclear\", \"Mechanism of upregulation after ischemia not addressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of SLBP as a direct degradation substrate of FEM1A (and FEM1B/C) via a distinct N-terminal degron established FEM1A as a ubiquitin-proteasome pathway component controlling cell-cycle-dependent histone mRNA metabolism, with evolutionary conservation from C. elegans to mammals.\",\n      \"evidence\": \"Co-immunoprecipitation, degron mutant analysis, cell-cycle expression profiling, C. elegans RNAi epistasis with CDL-1 readout\",\n      \"pmids\": [\"28118078\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full substrate repertoire beyond SLBP not defined\", \"Whether FEM1A recognizes SLBP via an Arg/C-degron or a different motif class not resolved\", \"Relative contributions of FEM1A vs. FEM1B/C to SLBP turnover not quantified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Crystal structures of FEM1A bound to Arg/C-degron substrates revealed the structural basis of substrate recognition and demonstrated that FEM1A and FEM1C select distinct Arg/C-degron classes compared to FEM1B, establishing the molecular logic of degron selectivity within the FEM1 family.\",\n      \"evidence\": \"X-ray crystallography of FEM1A–degron complexes, in vitro binding assays, GPS analysis, mutagenesis\",\n      \"pmids\": [\"33398168\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological substrates recognized via Arg/C-degrons in vivo not comprehensively catalogued\", \"How degron selectivity among FEM1A/B/C is regulated in different tissues remains unclear\", \"No structural information on FEM1A in complex with CUL2–RBX1 scaffold\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how FEM1A's mitochondrial localization in muscle cells relates to its CRL2 substrate receptor function, what the full in vivo substrate repertoire is, and whether FEM1A loss causally contributes to muscle disease or rhabdomyosarcoma.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No in vivo knockout phenotype reported\", \"Mitochondrial vs. cytosolic CRL2 activity not reconciled\", \"No disease-causative mutations identified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [\n      \"CRL2^FEM1A (CUL2-RBX1-ELOB/C-FEM1A)\"\n    ],\n    \"partners\": [\n      \"CUL2\",\n      \"SLBP\",\n      \"FEM1B\",\n      \"FEM1C\",\n      \"PTGER4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}